a clinical stage biopharmaceutical company
Industry Biotechnology
A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.
Ticker / NAME | Correlation To FATE | 1D Price Change % | ||
---|---|---|---|---|
FATE | 100% | -5.99% | ||
ALLO - FATE | 51% Loosely correlated | -4.56% | ||
VRDN - FATE | 50% Loosely correlated | -1.43% | ||
ABCL - FATE | 49% Loosely correlated | -2.34% | ||
NTLA - FATE | 48% Loosely correlated | -3.65% | ||
PRME - FATE | 47% Loosely correlated | -9.81% | ||
More |
Ticker / NAME | Correlation To FATE | 1D Price Change % |
---|---|---|
FATE | 100% | -5.99% |
biotechnology theme (248 stocks) | 50% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 48% Loosely correlated | +5.37% |
biopharmaceuticals theme (52 stocks) | 47% Loosely correlated | +2.00% |